Histological Assessment of NAFLD, Digestive Diseases and Sciences, vol.385, issue.5, pp.1348-55 ,
DOI : 10.1007/s10620-016-4062-0
Definition and natural history of metabolic steatosis : histology and cellular aspects. Diabetes Metab, pp.638-680, 2008. ,
The diagnosis and management of non-?alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, Liver Diseases, and American College of Gastroenterology. Gastroenterology, 2012. ,
Uber den Blutdruck bei Diabetes Mellitus, Wiener Arch Inn Med, vol.2, pp.461-467, 1921. ,
Synoptische betrachtung metabolischer risikofactoren, Lipidstoffwechselstorungen. Iéna : Gustav Fischer verlag, pp.254-64 ,
Das Metabolische Syndrom, Diabetologie und Stoffwechsel, vol.1, issue.5, pp.545-51, 1981. ,
DOI : 10.1055/s-2006-947258
Role of Insulin Resistance in Human Disease, Diabetes, vol.37, issue.12, pp.1595-607, 1988. ,
DOI : 10.2337/diab.37.12.1595
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation, Diabetic Medicine, vol.15, issue.7, pp.539-53, 1998. ,
DOI : 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
The metabolic syndrome???a new worldwide definition, The Lancet, vol.366, issue.9491, pp.1059-62, 2005. ,
DOI : 10.1016/S0140-6736(05)67402-8
Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, Circulation, vol.120, issue.16, pp.1640-1645, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.109.192644
Normal-?weight obese syndrome : early inflammation ? Am J Clin Nutr, 2007. ,
Obésité et surpoids Tiré de http://www.who.int/mediacentre/factsheets, p.79, 2016. ,
Diabète. Tiré de http, 2016. ,
Données épidémiologiques du diabète Tiré de http Organisation mondiale de la Santé, 2015. ,
Données épidémiologiques du diabète Tiré de http://www.invs.sante.fr/Dossiers-?thematiques/Maladies-?chroniques-?et-? traumatismes, 2015. ,
Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?, Diabetes & Metabolism, vol.42, issue.3, pp.142-56, 2016. ,
DOI : 10.1016/j.diabet.2016.04.002
Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women, Archives of Internal Medicine, vol.164, issue.10, pp.1066-76, 2004. ,
DOI : 10.1001/archinte.164.10.1066
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults, New England Journal of Medicine, vol.348, issue.17, pp.1625-1663, 2003. ,
DOI : 10.1056/NEJMoa021423
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy, Annals of Internal Medicine, vol.132, issue.2, pp.112-119, 2000. ,
DOI : 10.7326/0003-4819-132-2-200001180-00004
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity, Hepatology, vol.83, issue.6, pp.1387-95, 2004. ,
DOI : 10.1002/hep.20466
STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?, Gut, vol.55, issue.1, pp.123-153, 2006. ,
DOI : 10.1136/gut.2005.069757
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856395
Nonalcoholic fatty liver disease: From steatosis to cirrhosis, Hepatology, vol.99, issue.S1, pp.99-112, 2006. ,
DOI : 10.1002/hep.20973
Nonalcoholic Fatty Liver Disease in Severely Obese Subjects, The American Journal of Gastroenterology, vol.11, issue.2, pp.399-408, 2007. ,
DOI : 10.1007/BF00280883
Trésor-?Eco n°179 : obésité : quelles conséquences pour l'économie et comment les limiter Tiré de, 2016. ,
Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 2005. ,
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients, Hepatology, vol.100, issue.5, pp.1751-1760, 2012. ,
DOI : 10.1002/hep.25889
Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabetes Metab, pp.638-680, 2008. ,
Non-invasive means of measuring hepatic fat content, World Journal of Gastroenterology, vol.14, issue.22, pp.3476-83, 2008. ,
DOI : 10.3748/wjg.14.3476
Noninvasive Assessment of Hepatic Steatosis, Clinical Gastroenterology and Hepatology, vol.7, issue.2, pp.135-175, 2009. ,
DOI : 10.1016/j.cgh.2008.11.023
The utility of radiological imaging in nonalcoholic fatty liver disease, Gastroenterology, vol.123, issue.3, pp.745-50, 2002. ,
DOI : 10.1053/gast.2002.35354
Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study, Gut, vol.54, issue.1, pp.122-129, 2005. ,
DOI : 10.1136/gut.2003.036566
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774370
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis, Comparative Hepatology, vol.4, issue.1, p.10, 2005. ,
DOI : 10.1186/1476-5926-4-10
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data, PLoS ONE, vol.49, issue.3, p.30325, 2012. ,
DOI : 10.1371/journal.pone.0030325.s005
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population, BMC Gastroenterology, vol.23, issue.Suppl 2, p.33, 2006. ,
DOI : 10.1111/j.1365-2036.2006.02751.x
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors, Gastroenterology, vol.137, issue.3, pp.865-72, 2009. ,
DOI : 10.1053/j.gastro.2009.06.005
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease, Digestive and Liver Disease, vol.42, issue.7, pp.503-511, 2010. ,
DOI : 10.1016/j.dld.2009.08.002
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, vol.51, issue.10, 2014. ,
DOI : 10.1111/apt.12963
Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study, Gut, vol.55, issue.3, pp.403-411, 2006. ,
DOI : 10.1136/gut.2005.069153
Non-invasive evaluation of liver fibrosis using transient elastography, Journal of Hepatology, vol.48, issue.5, pp.835-882, 2008. ,
DOI : 10.1016/j.jhep.2008.02.008
Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations, European Journal of Gastroenterology & Hepatology, vol.18, issue.4, pp.411-413, 2006. ,
DOI : 10.1097/00042737-200604000-00015
Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations, Hepatology, vol.46, issue.3, pp.828-863, 2010. ,
DOI : 10.1002/hep.23425
Non-?invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-?offs of M probe to XL probe, Ann Hepatol, vol.12, issue.4, pp.570-80, 2013. ,
Non-?invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-?offs of M probe to XL probe, Ann Hepatol, vol.12, issue.4, pp.570-80, 2013. ,
Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients, Hepat Med, vol.5, pp.43-52, 2013. ,
Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan??, Journal of Hepatology, vol.56, issue.4, pp.833-842 ,
DOI : 10.1016/j.jhep.2011.10.017
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients, Hepatology, vol.53, issue.Suppl 1, pp.199-208, 2012. ,
DOI : 10.1002/hep.24624
Feasibility of liver transient elastography with FibroScan?? using a new probe for obese patients, Liver International, vol.49, issue.7, pp.1043-1051, 2010. ,
DOI : 10.1111/j.1478-3231.2010.02258.x
Controlled Attenuation Parameter (CAP): A Novel VCTE??? Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes, Ultrasound in Medicine & Biology, vol.36, issue.11, pp.1825-1860, 2010. ,
DOI : 10.1016/j.ultrasmedbio.2010.07.005
Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy, Ultrasound in Medicine & Biology, vol.42, issue.1, pp.92-103, 2016. ,
DOI : 10.1016/j.ultrasmedbio.2015.08.008
Controlled attenuation parameter for the diagnosis of steatosis in non-?alcoholic fatty liver disease, J Gastroenterol Hepatol. 2016, vol.31, issue.4, pp.848-55 ,
Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, vol.128, issue.4, pp.865-73, 2006. ,
DOI : 10.1002/hep.21327
Long term prognosis of fatty liver: risk of chronic liver disease and death, Gut, vol.53, issue.5, pp.750-755, 2004. ,
DOI : 10.1136/gut.2003.019984
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.149, issue.2, pp.389-97, 2015. ,
DOI : 10.1053/j.gastro.2015.04.043
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up, Hepatology, vol.57, issue.5, pp.1547-54, 2015. ,
DOI : 10.1002/hep.27368
Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.145, issue.4, pp.782-791, 2013. ,
DOI : 10.1053/j.gastro.2013.06.057
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease, Journal of Hepatology, vol.65, issue.3, 2016. ,
DOI : 10.1016/j.jhep.2016.04.023
Fatty liver index and mortality: The cremona study in the 15th year of follow-up, Hepatology, vol.34, issue.1, pp.145-52, 2011. ,
DOI : 10.1002/hep.24356
Disparités régionales de la mortalité prématurée par maladie cardio-?vasculaire en France, 2008. ,
Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia, Alimentary Pharmacology & Therapeutics, vol.12, issue.9, pp.1081-93, 2014. ,
DOI : 10.1111/apt.12946
Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis, PLOS ONE, vol.28, issue.Suppl 2, p.128774, 2015. ,
DOI : 10.1371/journal.pone.0128774.t004
NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients, World Journal of Gastroenterology, vol.19, issue.8, pp.1219-1248, 2013. ,
DOI : 10.3748/wjg.v19.i8.1219
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587478
Noninvasive tests for fibrosis and liver stiffness predict 5-?year outcomes of patients with chronic hepatitis C. Gastroenterology, pp.1970-1979, 1979. ,
Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus, Alimentary Pharmacology & Therapeutics, vol.16, issue.10, pp.979-88, 2013. ,
DOI : 10.1111/apt.12307
Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography, Hepatology, vol.19, issue.Suppl 1, pp.1954-61, 2009. ,
DOI : 10.1002/hep.22870
Expanding consensus in portal hypertension, Journal of Hepatology, vol.63, issue.3, pp.743-52, 2015. ,
DOI : 10.1016/j.jhep.2015.05.022
Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study, Journal of Gastroenterology and Hepatology, vol.56, issue.2, 2016. ,
DOI : 10.1111/jgh.13503